Literature DB >> 2039702

Medical history and the risk of multiple myeloma.

A Gramenzi1, I Buttino, B D'Avanzo, E Negri, S Franceschi, C La Vecchia.   

Abstract

The relationship between various diseases and immunisations and the risk of multiple myeloma was analysed using data from a hospital-based case-control study conducted in Northern Italy on 117 patients with multiple myeloma and 477 controls. Associations were observed for clinical history of scarlet fever (relative risk, RR = 2.0; 95% confidence interval, CI = 1.1-3.9), tuberculosis (RR = 2.3%; 95% CI = 0.9-5.7) and BCG immunisation (RR = 3.0; 95% CI = 1.4-6.4). The relative risk was 1.8 (95% CI = 0.9-3.5) for episodes of Herpes zoster infection, but most of the excess cases occurred within 10 years of diagnosis, suggesting that this might have been an early manifestation of the disease. No association emerged for common childhood viral infections or any other immunisation practice. When various classes of infectious or inflammatory diseases were grouped together according to their aetiology, there was a significant positive association with chronic bacterial illnesses (RR = 1.8; 95% CI = 1.1-2.8), and the relative risk estimates increased with the number of bacterial diseases. The trend in risk with number of diseases was significant (chi 21 = 4.5, P = 0.03). A negative association was found between allergic conditions and risk of multiple myeloma (RR = 0.6; 95% CI = 0.3-1.0).

Entities:  

Mesh:

Year:  1991        PMID: 2039702      PMCID: PMC1972384          DOI: 10.1038/bjc.1991.172

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  26 in total

1.  A case-control study of multiple myeloma nested in the American Cancer Society prospective study.

Authors:  P Boffetta; S D Stellman; L Garfinkel
Journal:  Int J Cancer       Date:  1989-04-15       Impact factor: 7.396

2.  Multiple myeloma in Western Australia: a case-control study in relation to occupation, father's occupation, socioeconomic status and country of birth.

Authors:  A Nandakumar; B K Armstrong; N H de Klerk
Journal:  Int J Cancer       Date:  1986-02-15       Impact factor: 7.396

3.  Repeated stimulation of the reticuloendothelial system and the development of plasma-cell dyscrasias.

Authors:  R Penny; S Hughes
Journal:  Lancet       Date:  1970-01-10       Impact factor: 79.321

4.  Medical history and primary liver cancer.

Authors:  C La Vecchia; E Negri; B D'Avanzo; P Boyle; S Franceschi
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

5.  Antigenic stimulation and the occurrence of multiple myeloma.

Authors:  T D Koepsell; J R Daling; N S Weiss; J W Taylor; A F Olshan; J L Lyon; G M Swanson; M Child
Journal:  Am J Epidemiol       Date:  1987-12       Impact factor: 4.897

6.  Comparison of trends in the incidence of multiple myeloma in Malmö, Sweden, and other countries, 1950-1979.

Authors:  I Turesson; O Zettervall; J Cuzick; J G Waldenstrom; R Velez
Journal:  N Engl J Med       Date:  1984-02-16       Impact factor: 91.245

7.  Multiple myeloma in Swedish agricultural workers.

Authors:  G Steineck; K Wiklund
Journal:  Int J Epidemiol       Date:  1986-09       Impact factor: 7.196

8.  Family history of autoimmune disorders and cancer in multiple myeloma.

Authors:  M S Linet; J K Mclaughlin; S D Harlow; J F Fraumeni
Journal:  Int J Epidemiol       Date:  1988-09       Impact factor: 7.196

9.  Cancer mortality in Italy: an overview of age-specific and age-standardised trends from 1955 to 1984.

Authors:  C La Vecchia; E Negri; A Decarli; M Fasoli; C Cislaghi
Journal:  Tumori       Date:  1990-04-30

10.  Multiple myeloma--a case-control study.

Authors:  J Cuzick; B De Stavola
Journal:  Br J Cancer       Date:  1988-05       Impact factor: 7.640

View more
  12 in total

1.  Leukemia, lymphoma, and multiple myeloma following selected medical conditions.

Authors:  M M Doody; M S Linet; A G Glass; G D Friedman; L M Pottern; J D Boice; J F Fraumeni
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

2.  Is herpes zoster a marker for occult or subsequent malignancy?

Authors:  Frank Buntinx; Richard Wachana; Stefaan Bartholomeeusen; Kathleen Sweldens; Helena Geys
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

3.  Herpes Zoster and Risk of Cancer in the Elderly U.S. Population.

Authors:  Parag Mahale; Elizabeth L Yanik; Eric A Engels
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-11-17       Impact factor: 4.254

4.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

5.  Common community-acquired infections and subsequent risk of multiple myeloma: a population-based study.

Authors:  Charlene M McShane; Liam J Murray; Eric A Engels; Ola Landgren; Lesley A Anderson
Journal:  Int J Cancer       Date:  2013-10-12       Impact factor: 7.396

6.  Multiple myeloma among blacks and whites in the United States: the role of chronic antigenic stimulation.

Authors:  D R Lewis; L M Pottern; L M Brown; D T Silverman; R B Hayes; J B Schoenberg; R S Greenberg; G M Swanson; A G Schwartz; J M Liff
Journal:  Cancer Causes Control       Date:  1994-11       Impact factor: 2.506

7.  The Association between Herpes Zoster and Increased Cancer Risk: A Nationwide Population-Based Matched Control Study.

Authors:  Ji-Hoon Sim; Hyun-Seok Cho; Young-Do Kim; Juhan Mun; Sung-Bae Kim; Jong-Hyuk Lee; Jeong-Gil Leem
Journal:  Curr Oncol       Date:  2021-07-17       Impact factor: 3.677

8.  Association between recent herpes zoster but not herpes simplex infection and subsequent risk of malignancy in women: a retrospective cohort study.

Authors:  F Buntinx; S Bartholomeeusen; A Belmans; C Mathei; G Opdenakker; K Sweldens; C Truyers; M Van Ranst
Journal:  Epidemiol Infect       Date:  2013-08-02       Impact factor: 4.434

9.  Childhood infectious diseases and risk of multiple myeloma: an analysis of the Italian multicentre case-control study.

Authors:  E Stagnaro; S Parodi; A Seniori Costantini; P Crosignani; L Miligi; O Nanni; S Piro; V Ramazzotti; S Rodella; R Tumino; C Vindigni; P Vineis
Journal:  Epidemiol Infect       Date:  2018-05-30       Impact factor: 4.434

10.  Herpes zoster is associated with an increased risk of subsequent lymphoid malignancies - a nationwide population-based matched-control study in Taiwan.

Authors:  Yi-Chang Liu; Yi-Hsin Yang; Hui-Hua Hsiao; Wen-Chi Yang; Ta-Chih Liu; Chao-Sung Chang; Ming-Yu Yang; Pai-Mei Lin; Jui-Feng Hsu; Pi-Yu Chang; Sheng-Fung Lin
Journal:  BMC Cancer       Date:  2012-10-31       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.